Jpmorgan Chase & CO Enovis Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENOV
# of Institutions
303Shares Held
61.2MCall Options Held
1.63MPut Options Held
576K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.64MShares$282 Million0.19% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$230 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$227 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.15MShares$134 Million0.04% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$127 Million0.54% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.3B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...